South African Druggists Ltd. v Pfizer Inc. (612/87) [1989] ZASCA 65 (26 May 1989)
The Supreme Court of Appeal held that the respondent had not derived adequate remuneration from the patent, as the delay in commercial exploitation was due to necessary development, testing, and regulatory approval—factors extraneous to the invention itself. The Court rejected the appellant's argument that the respondent recouped lost remuneration by increasing prices, finding that the recoupment reasoning is not a valid legal principle and that the prices for Feldene were competitive and not loaded. The respondent was not at fault for the lost time, and the invention did not suffer from inherent weaknesses preventing exploitation. The Court found that the actual remuneration was...
- Citation
- [1989] ZASCA 65
- Parties
- Appellant: South African Druggists Limited; Respondent: Pfizer Inc.
- Court
- Supreme Court of Appeal
- Jurisdiction
- South Africa
- Judgment Date
- 26 May 1989
- Case Number
- 612/87
- Procedural Posture
- Civil Appeal / Appeal From the Transvaal Provincial Division Against the Order Granting Extension of Patent Term
- Outcome
- Appeal dismissed with costs, including the fees of two counsel.
- Judges
- Corbett, Hoexter, Nestadt, Kumleben, Nicholas
- Legal Topics
- Patent Extension, Adequate Remuneration, Lost Time Principle, Competitive Pricing, Discretion of Commissioner
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
South African Druggists Limited
Appellant
Pfizer Inc.
Respondent
Procedural Posture
Civil Appeal / Appeal From the Transvaal Provincial Division Against the Order Granting Extension of Patent Term
Legal Issues
- 1 Whether the patentee derived adequate remuneration from the patent within the meaning of section 39(1)(a) of the Patents Act.
- 2 Whether the delay in commercial exploitation was due to extraneous factors or inherent weaknesses in the invention.
- 3 Whether the respondent recouped lost remuneration by increasing prices after commencing sales.
Ratio Decidendi
The Supreme Court of Appeal held that the respondent had not derived adequate remuneration from the patent, as the delay in commercial exploitation was due to necessary development, testing, and regulatory approval—factors extraneous to the invention itself. The Court rejected the appellant's argument that the respondent recouped lost remuneration by increasing prices, finding that the recoupment reasoning is not a valid legal principle and that the prices for Feldene were competitive and not loaded. The respondent was not at fault for the lost time, and the invention did not suffer from inherent weaknesses preventing exploitation. The Court found that the actual remuneration was...
Court Disposition
Appeal dismissed with costs, including the fees of two counsel.
Orders
- The appeal is dismissed.
- The appellant is ordered to pay the costs of the appeal, including the fees of two counsel.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment